Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction

Authors

Essraa Bayoumi, Washington DC VA Medical Center
Phillip H. Lam, Washington DC VA Medical Center
Daniel J. Dooley, Washington DC VA Medical Center
Steven Singh, Washington DC VA Medical Center
Charles Faselis, Washington DC VA Medical Center
Charity J. Morgan, The University of Alabama at Birmingham
Samir Patel, Washington DC VA Medical Center
Helen M. Sheriff, Washington DC VA Medical Center
Selma F. Mohammed, Washington Hospital Center
Carlos E. Palant, The George Washington University
Bertram Pitt, University of Michigan, Ann Arbor
Gregg C. Fonarow, University of California, Los Angeles
Ali Ahmed, Washington DC VA Medical Center

Document Type

Journal Article

Publication Date

1-1-2019

Journal

American Journal of Medicine

Volume

132

Issue

1

DOI

10.1016/j.amjmed.2018.09.011

Keywords

Ejection fraction; Heart failure; Mortality; Readmission; Spironolactone

APA Citation

Bayoumi, E., Lam, P., Dooley, D., Singh, S., Faselis, C., Morgan, C., Patel, S., Sheriff, H., Mohammed, S., Palant, C., Pitt, B., Fonarow, G., & Ahmed, A. (2019). Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction. American Journal of Medicine, 132 (1). http://dx.doi.org/10.1016/j.amjmed.2018.09.011